The Prevalence, Incidence And Natural History Of Anal Cellular Abnormalities In Mature-aged Homosexual Men
Funder
National Health and Medical Research Council
Funding Amount
$144,725.00
Summary
Anal cancer is one of the most common cancers in homosexual men and rates in Australia are now higher than those of cervical cancer prior to the introduction of routine cervical screening in women. The Mature Aged Gay MenÍs Anal Health Study will enrol 1000 men over 45 years old and follow them for up to 5 years to investigate the progression of anal pre-cancerous lesions in men and the potential of a screening program to allow early detection of these lesions.
Reducing The Burden Of Cancer In Chronic Kidney Disease
Funder
National Health and Medical Research Council
Funding Amount
$257,561.00
Summary
Chronic kidney disease (CKD) is an important public health problem in Australia and worldwide. Not only does CKD predisposes to end-stage kidney disease, but more importantly, increases the risk of co-morbidities such as cancer and cardiovascular disease, leading to premature death. As an academic nephrologist with interests in clinical epidemiology, health economics and translation research, this proposed program of work will focus on assessing the critical areas in improving the cancer outcome ....Chronic kidney disease (CKD) is an important public health problem in Australia and worldwide. Not only does CKD predisposes to end-stage kidney disease, but more importantly, increases the risk of co-morbidities such as cancer and cardiovascular disease, leading to premature death. As an academic nephrologist with interests in clinical epidemiology, health economics and translation research, this proposed program of work will focus on assessing the critical areas in improving the cancer outcomes in patients with CKD.Read moreRead less
Use Of Molecular Tumour Markers To Improve Diagnostic Performance Of Bronchoscopy In Assessment Of Pulmonary Nodules And Early Diagnosis Of Lung Cancer
Funder
National Health and Medical Research Council
Funding Amount
$303,014.00
Summary
Pulmonary nodules may represent early lung cancer though difficulty in accurate diagnosis means many patients experience delayed diagnosis, or unnecessary surgical biopsy or repeat CT imaging (& consequent radiation exposure). I will identify molecular (DNA, protein) markers in bronchoscopic & blood specimens to accurately characterize malignant & benign nodules. These biomarkers will also be investigated for their value as a non-invasive screening test for lung cancer
Reducing Disparities In Cervical Cancer Incidence For Aboriginal And Torres Strait Islander Women Through Screening And Vaccination
Funder
National Health and Medical Research Council
Funding Amount
$329,768.00
Summary
This program of research will aim to reduce cervical cancer incidence for Indigenous women by developing and trialling health systems interventions to increase cervical screening participation and HPV vaccination coverage. This research will be led by an Indigenous researcher with Indigenous people and for Indigenous people.
Cause Of Death In Men With Prostate Cancer: A Population-wide Data Linkage Study
Funder
National Health and Medical Research Council
Funding Amount
$305,255.00
Summary
3,000 Australians die of prostate cancer annually yet 100,000 are living with the disease. This project will identify the causes of death in men with prostate cancer. It will examine whether testing for the disease lowers the risk of death, whether patients are at higher risk of suicide or heart disease and if type of treatment is related to long term risk of heart disease. The results will help men and their doctors make informed decisions about testing and treatment for prostate cancer.
A Piggy-back Screen For Genes Involved In Cancer Epigenetics
Funder
National Health and Medical Research Council
Funding Amount
$302,123.00
Summary
Cancer can be caused not only by mutations in genes, but also by changes to our epigenome, which controls whether genes are on or off. There is much still to learn about the epigenome. We have developed a method to identify epigenome regulators. The epigenome is disrupted in cancer, but it is not know whether this starts tumour growth. I will use mutant mice to study this and analyse human cancers for mutations in epigenome regulators. This may lead to preventative screening and new treatments.